Dementia Matters6 Heinä 2021

From Studying to Living with Alzheimer‘s Disease: A Conversation with Dr. Daniel Gibbs

Neurologist and author Daniel Gibbs, PhD, joins the podcast to discuss his recent book, “A Tattoo on My Brain,” which details his journey from treating Alzheimer’s disease clinically for 25 years to being diagnosed with early-stage Alzheimer’s. Dr. Gibbs discusses early signs he experienced and daily life with the disease, as well as thoughts on the recent FDA-approved treatment aducanumab (marketed as Aduhelm).

Guest: Daniel Gibbs, PhD, neurologist

Episode Topics

What inspired the title of your book, “A Tattoo on the Brain”? 1:01
What were these early signs of Alzheimer's disease that you recognized in yourself? 3:42
What were your impressions of the clinic process, and where is there room for improvement? 8:08
Can you share your view on family history? 9:17
What do you say to people about direct-to-consumer genetic testing, both as a recipient and as a clinician? 10:57
Did knowing your risk of Alzheimer's disease help or harm you? 12:42
Did you find any habit difficult to incorporate into your day? 13:17
How important was it for you to be involved in research and what did you gain from being a research participant? 17:15
How do you feel about the recent FDA approval of aducanumab for clinical use? 20:25
As a patient, would you sign up for this drug, and if you were still working as a neurologist, would you prescribe this drug? 22:59
How do you find the balance between enjoying daily life and engaging proactive activities meant to improve the future? 24:49
How can we reframe the way people understand Alzheimer's disease? 28:18
Was it difficult to publicly discuss your experience, and what have you learned from this process? 29:52
What do you hope the reader takes away from your book? 31:15

Find Dementia Matters online

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(247)

Looking at More than Memory: Functional Assessments and Blood Tests for Alzheimer's Disease in Primary Care

Though new blood-based biomarker tests have made it less expensive, less invasive and more accessible to diagnose Alzheimer’s disease, they can’t replace the diagnostic process as a whole. Dr. Eric Wi...

6 Loka 48min

Examining Environmental Factors' Effects on Cognition

New research is looking at the effects of environmental factors on the brain as we age. Dr. Kathryn Conlon joins the podcast to discuss how factors like air pollution and lead exposure can affect cogn...

22 Syys 42min

Blood Tests and Brain Scans and Biomarkers, Oh My! How Biomarkers are Changing Alzheimer’s Disease Clinical Trials

In recent years, the U.S. Food and Drug Administration (FDA) has approved new biomarker tools for Alzheimer’s disease, including blood tests and tracers for brain scans. How are these tools used in re...

8 Syys 45min

New Alzheimer’s Association Special Report Breaks Down How Americans Understand and Support their Brain Health

In recent years, public interest in brain health has increased. So how are Americans understanding brain health information and incorporating it into their own lives? This year, the Alzheimer’s Associ...

25 Elo 37min

Reflecting on 25 Years of the Wisconsin Registry for Alzheimer’s Prevention

Twenty-five years ago, a single participant enrolled in what would become the Wisconsin Registry for Alzheimer's Prevention (WRAP), now one of the largest and longest-running studies of Alzheimer's ri...

12 Elo 35min

How Dementia Caregiving Affects the Spousal Caregiver

Caring for those with dementia represents a major public health challenge, with caregivers, especially spouses, providing long-term, largely unpaid care. With caregiving stress linked to a decline in ...

28 Heinä 39min

Managing the Medicine Cabinet: How Prescriptions Impact Cognition and Brain Health as We Age

Prescription medications, over-the-counter drugs and supplements are incredibly common among older adults, yet many of these routine treatments can unexpectedly impact cognitive function and brain hea...

14 Heinä 35min

Taking a Deep Dive into Subjective Cognitive Decline

Dr. Jessen returns to the podcast to take a deeper dive into subjective cognitive decline (SCD). Aiming to cover everything relating to SCD, Dr. Jessen shares insights in prognosis, risk factors and h...

7 Heinä 17min